6,320
+3.27%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About FutureChem Co
Its shares trade on KOSDAQ under the ticker 220100.KQ. It has been listed since 13 August 2015. In the fiscal year to 31 December 2025, it reported revenue of ₩18.67bn and a net loss of ₩11.25bn. At that date it held total assets of ₩74.53bn and shareholders' equity of ₩54.65bn.
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 13 Aug 2015
- Website
- futurechem.co.kr ↗
Leadership
Pay as last reported
- Mr. Dae Yun JiPresident, Chief Executive Officer, Director
- Mr. Yeong Yil YooChief Financial Officer, Assistant Managing Director
- Mr. Hui Seop GilChief Technology Officer, Assistant Managing Director
- Ms. Yeong Ja ParkManaging Director
- Mr. Cheol KimInternal Auditor
- Mr. Won Jung YoonAssistant Managing Director
- Mr. Guk Cheol JungOther Non-Executive Director
- Mr. Jun Gi JungOther Non-Executive Director
- Mr. Cheol Su LeeOther Non-Executive Director
- Mr. Hun MaOther Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- FutureChem Co Ltd manufactures radiopharmaceuticals for cancer diagnosis and early detection of Parkinson's and Alzheimer's disease.
- The company produces medical automation modules including cubes and disposable cassettes for healthcare applications.
- FutureChem Co Ltd develops PET and SPECT precursors for radiopharmaceuticals and other chemicals like metal chelating agents.
Weaknesses
- FutureChem Co Ltd is headquartered in Seoul, South Korea, limiting global market reach.
- The company's business is focused on radiopharmaceuticals, which may face regulatory challenges in some regions.
- FutureChem Co Ltd's IPO in 2015 may indicate limited financial flexibility for rapid expansion.
Opportunities
- FutureChem Co Ltd can expand its radiopharmaceuticals for cancer diagnosis in the growing Asian healthcare market.
- The company can leverage PET and SPECT precursors for increasing demand in medical imaging technologies.
- FutureChem Co Ltd can target Parkinson's and Alzheimer's disease diagnostics in aging populations globally.
Threats
- FutureChem Co Ltd faces competition from established radiopharmaceutical manufacturers in the Health Care sector.
- Regulatory changes in South Korea could impact the production and distribution of radiopharmaceuticals.
- Global economic downturns may reduce healthcare spending on advanced diagnostic tools like PET and SPECT.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.